Abstract
There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being piloted. Most of these trials have as an endpoint the restoration of dystrophin in muscle fibers, hence requiring sufficiently well-preserved muscle of recruited patients. The choice of the muscles to be studied and the role of noninvasive methods to assess muscle preservation therefore require further evaluation.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 346-353 |
| Numero di pagine | 8 |
| Rivista | Neurology |
| Volume | 76 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2011 |
Keywords
- Adolescent
- Child
- Foot
- Humans
- Leg
- Magnetic Resonance Imaging
- Male
- Muscle, Skeletal
- Muscular Dystrophy, Duchenne
Fingerprint
Entra nei temi di ricerca di 'Muscle histology vs MRI in Duchenne muscular dystrophy'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver